Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.20) by 65 percent. This is a 800 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $12.355 million which beat the analyst consensus estimate of $12.013 million by 2.85 percent. This is a 11.76 percent decrease over sales of $14.001 million the same period last year.